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The mitogen-activated protein kinase (MAPK) 
p38 has a critical role in proinflammatory re-
sponses (Lu et al., 2010; Jirmanova et al., 2011; 
Noubade et al., 2011). Like all MAPKs, p38 
is activated by a cascade in which upstream 
MAPK kinases (MAPKKs) phosphorylate 
Thr-180 and Tyr-182 in the activation loop (dual 
phosphorylation, the classical pathway) leading 
to p38-mediated phosphorylation of substrates 
involved in enhanced gene transcription and 
mRNA stability (Pearson et al., 2001; Wu et al., 
2003). T cells possess an additional activation 
pathway downstream of the TCR in which the 
tyrosine kinase Zap70 phosphorylates p38 on 
Tyr-323, leading to automonophosphorylation 
of Thr-180 (monophosphorylation of the acti-
vation loop, the alternative pathway; Salvador 
et al., 2005; Mittelstadt et al., 2009). Studies with 
dual versus monophosphorylated p38 have shown 
that the potency and substrate fine-specificity of 
these forms differ (Mittelstadt et al., 2009), rais-
ing the possibility that these two phosphorylated 
species may have different roles in vivo.
Alternatively activated p38 plays an impor-
tant role in T cell–mediated autoimmunity. For 
example, Gadd45 is a constitutive inhibitor of 
Tyr-323–phosphorylated (pY323) p38, and in 
its absence chronic activation of alternatively 
activated T cell p38 results in autoimmune vas-
culitis (Salvador et al., 2002). Conversely, inac-
tivation of the alternative pathway by replacing 
endogenous p38 and p38 with mutants with 
a Tyr→Phe substitution at residue 323 (double 
knock-in [DKI] mice) prevents autoimmu-
nity in Gadd45 knockout mice and reduces 
disease severity in the murine disease models 
experimental autoimmune encephalomyelitis 
(EAE) and collagen-induced arthritis (CIA; 
Jirmanova et al., 2011). In this regard, Th17 cells 
constitute a CD4+ T helper subtype that medi-
ates both protective and harmful immune re-
sponses (Korn et al., 2009). Whereas Th17 cells 
provide protection in response to infections 
such as Klebsiella pneumoniae (Aujla et al., 2008) 
and Citrobacter rodentium (Curtis and Way, 2009), 
robust Th17 activity is a major contributor to 
autoimmune diseases such as multiple sclerosis 
(Kebir et al., 2007) and rheumatoid arthritis 
(Pernis, 2009), as well as the autoimmune models 
EAE and CIA (Nakae et al., 2003; Komiyama 
et al., 2006). Th17 differentiation is achieved by 
stimulation via the TCR in combination with 
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manifested in human psoriatic lesions, in which IL-17A pro-
duction by p38 pY323+-infiltrating T cells was greatly reduced 
by treatment with UV.
RESULTS
p38 alternative activation is required for TCR-induced  
up-regulation of NFATc1 and IRF4
The p38 alternative activation is an important step for TCR-
signaled T cell proliferation, differentiation, and effector func-
tion (Jirmanova et al., 2009, 2011). To determine which genes 
are downstream of this form of activated p38, a cDNA micro-
array analysis was performed on CD4+ T cells from WT and 
DKI mice stimulated with anti-CD3/CD28. From among 
the 100 genes that were decreased 1.5-fold or more in DKI 
compared with WT cells, 12 of the of annotated genes were 
of immunological interest, and one-third of these have been 
identified as downstream of the NFAT family of transcription 
factors. For example, expression of Apobec3, a cytidine de-
aminase whose human analogue, APOBEC3G, is regulated by 
NFATc1 and IRF4 and is a key molecule in antiviral immu-
nity (Farrow et al., 2011), was roughly fourfold higher in WT 
compared with DKI T cells. Other NFAT-regulated targets 
such as Thioredoxin 1 (encoded by Txn1), which inhibits cel-
lular TNF liberation by suppressing the protease ADAM17 
(Aragão et al., 2012), and Schlafen 1 (encoded by Slfn1), 
which is involved in T cell development (Schwarz et al., 1998; 
Blomberg et al., 2009), were also expressed at lower levels in 
DKI than WT T cells, as was Irf4. The diminished expression 
of Apobec3 mRNA and protein in DKI T cells was con-
firmed by real-time PCR and immunoblotting (unpublished 
data), validating the microarray results that it is indeed down-
stream of and utilizes the p38 alternative pathway.
The finding that up-regulation of several NFAT-dependent 
genes was decreased in TCR-signaled DKI T cells prompted 
us to first ask if expression of NFATc1, the only family mem-
ber that is induced at the transcriptional level, and IRF4, 
also upstream of cytokine expression, are regulated by p38 in 
T cells. Anti-CD3 induced NFATc1 and IRF4 up-regulation 
in CD4+ T cells was prevented by SB203580, a p38 and 
p38 catalytic inhibitor (Fig. 1 A). The effect was specific in 
that up-regulation of another inducible IRF family member, 
IRF8, was not prevented by inhibiting p38. To determine if 
p38-dependent up-regulation of IRF4 is independent, or 
downstream, of NFAT, CD4+ T cells were stimulated via the 
TCR in the presence of the cell-permeable, NFAT-specific 
inhibitor 11R-VIVIT. Induction of IRF4 mRNA (Fig. 1 B) 
and protein (Fig. 1 C) was prevented by 11R-VIVIT but not 
the inactive peptide 11R-VEET. The contribution of alterna-
tively activated as opposed to MAPK cascade-activated p38 
was addressed with CD4+ T cells from DKI mice. Induction 
of NFATc1 and IRF4 was markedly impaired in DKI CD4+ 
T cells at both the mRNA (Fig. 1 D) and protein (Fig. 1 E) 
levels. In contrast, expression of other NFAT (Nfatc2, Nfatc3, 
and Nfatc5) and IRF (Irf8) family members did not differ 
between TCR-stimulated WT and DKI mice (unpublished 
data). Remarkably, stimulation with PMA and ionomycin, 
IL-6 and TGF, with subsequent survival promoted by IL-23 
(Bettelli et al., 2006; Zhou et al., 2007), and the effects of acti-
vated Th17 cells are mediated via effector cytokines such as 
IL-17 and IL-22 (Korn et al., 2009). In addition to retinoic 
acid–related orphan receptor RORt (encoded by Rorc), 
ROR, c-Maf, and AhR (aryl hydrocarbon receptor), recent 
discoveries have implicated IRF4 as playing a key role in 
Th17 differentiation (Brüstle et al., 2007; Veldhoen et al., 
2008; Yang et al., 2008; Korn et al., 2009; Sato et al., 2011). 
Importantly, IRF4 has been shown to bind the IL-17A pro-
moter and induce its activity (Mudter et al., 2011). Although 
alternatively activated p38 has been implicated as a positive regu-
lator of Th17 differentiation (Jirmanova et al., 2011; Noubade 
et al., 2011), the molecular mechanism, and in particular 
the role of p38 in induction of these transcription factors, 
is unknown.
Nuclear factor of activated T cells (NFAT) family mem-
ber activity is required for many T cell effector functions, 
and cyclosporin A (CsA), a pharmacological inhibitor of the 
NFAT signaling pathway, inhibits IRF4 expression (Cristillo 
and Bierer, 2002) and Th17 differentiation (Cho et al., 2007; 
Zhang et al., 2008). The NFAT family consists of five mem-
bers: NFATc1 (also known as NFATc or NFAT2), NFATc2 
(also known as NFATp or NFAT1), NFATc3 (also known as 
NFAT4 or NFATx), NFATc4 (also known as NFAT3), and 
NFAT5. Except for NFAT5, which is activated by osmotic 
stress, NFAT family members are activated by calcium signal-
ing (Macian, 2005). In the resting state, NFAT proteins are 
phosphorylated on multiple serine residues by kinases such 
as glycogen synthase kinase 3 (GSK3), casein kinase 1 (CK1), 
and the stress kinases p38 and Jun N-terminal kinases (JNK; 
Chow et al., 2000; Porter et al., 2000; Macian, 2005). NFAT 
phosphorylation results in cytosolic retention due to masking 
of nuclear localization sequences, exposure of a nuclear ex-
port sequence, and/or binding to cytoplasmic proteins such as 
14–3-3 (Chow and Davis, 2000). Stimuli that lead to increased 
intracellular Ca2+ levels activate the phosphatase calcineurin, 
which dephosphorylates NFATs and allows them to migrate 
to the nucleus and regulate the transcription of target genes 
(Macian, 2005). Although the main mode of NFAT regula-
tion is via calcium and calcineurin, NFATc1 is uniquely regu-
lated in T cells at the transcriptional level, being up-regulated 
by mitogenic stimuli (Macian, 2005).
Although the alternative T cell p38 activation pathway has 
been implicated in T cell responses in vitro and in vivo, the 
molecular mechanisms by which it mediates it actions are 
unknown. Moreover, why TCR signaling utilizes a unique 
pathway, and not the conventional MAP kinase cascade (as it 
does for the MAPK ERK, for example; Koike et al., 2003) is 
an unanswered question. Here, we explored these issues and 
found that alternatively activated p38 is required for induc-
tion of the key transcription factors NFATc1 and IRF4 and 
downstream differentiation and effector functions of Th17 
cells. Moreover, these responses were antagonized by MAPK 
cascade-activated p38 because of phosphorylation, cytoplas-
mic sequestration, and inactivation of NFATc1. This was also 
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in IRF4 knockout mice (Cristillo and Bierer, 2002; Brüstle 
et al., 2007; Tsuda et al., 2012). Therefore, the ability of stimu-
lation via the TCR versus PMA plus ionomycin to skew CD4+ 
T cells was investigated. As shown in Fig. 1 F, naive CD4+  
T cells cultured under neutral (Th0) or Th17-skewing (Th17) 
conditions expressed more IFN- and IL-17A (both in terms of 
numbers of positive cells and the amount of cytokine produced), 
which bypasses the TCR and activates p38 via the MAPK 
cascade, induced much less NFATc1 and IRF4 compared 
with stimulation via the TCR (Fig. 1 E). Blockade of NFAT 
pathway by CsA impairs IFN- and IL-17 expression and 
Th17 development (Granelli-Piperno et al., 1984; Tsuda 
et al., 2012). Moreover, CsA inhibits the expression of the 
transcription factor IRF4, and Th17 development is blocked 
Figure 1. p38 Alternative activation is required for TCR-induced expression of NFATc1 and IRF4 in CD4+ T cells. (A) Purified CD4+ T cells  
were stimulated with anti-CD3/CD28 in the presence or absence of SB203580 and immunoblotted for the indicated transcription factors 48 h later.  
(B and C) Purified CD4+ T cells were stimulated with anti-CD3/CD28 in the presence of 11R-VIVIT or 11R-VEET. Irf4 mRNA (B) and protein (C) were deter-
mined 24 h later. (D and E) Purified CD4+ T cells from WT and DKI mice were stimulated with anti-CD3/CD28 or PMA plus ionomycin, as indicated for the 
indicated times and analyzed for expression of Nfatc1 and Irf4 mRNA (D) and protein (E). Results shown in A–E are representative of three independent 
experiments each. (F) Naive CD4+ T cells were stimulated with either anti-CD3/CD28 or PMA and ionomycin under neutral or Th17-skewing conditions for 3 d. 
IL-17A and IFN- expression were determined by intracellular staining and flow cytometry after restimulation with PMA and ionomycin. Results shown in 
the left panel are representative of three independent experiments and bar graphs in the right panel show the mean ± SEM of all three. *, P < 0.05 (un-
paired two-tailed Student’s t test).
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C. rodentium, for which Th17 cells plays a critical protective 
role (Curtis and Way, 2009). Mice were analyzed at 11–12 d 
after infection, which is normally at or near the peak of the 
response (Johnson and Barthold, 1979). WT mice had more 
infiltrating lymphocytes in the colonic lamina propria (LP) 
than DKI mice (Fig. 2 A), and freshly isolated LP CD4+  
T cells from DKI mice expressed much lower levels of Rorc and 
Irf4, transcription factors required for Th17 differentiation, 
than their WT counterparts (Fig. 2 B). Correspondingly, Il17a 
mRNA and protein expression was highly impaired in lamina 
propria CD4+ DKI T cells (Fig. 2, B and C). In agreement with 
respectively, when skewing was performed in the presence of 
anti-CD3/CD28 compared with PMA and ionomycin at a con-
centration that results in robust T cell activation (see also Fig. 4 C, 
right). Together, these results indicate that activation of p38 via 
the TCR, but not the MAPK cascade, is required for induction 
of NFATc1 and IRF4 and efficient cytokine production.
DKI mice have a defective Th17 response  
to Citrobacter rodentium
To test the importance of p38 alternative activation in a 
physiological setting, WT and DKI mice were infected with 
Figure 2. DKI mice have a defective Th17 response 
to infection with C. rodentium. (A) WT and DKI mice 
were infected with C. rodentium by gavage and at day 
11–12 cells in the LP were counted. Each symbol repre-
sents one mouse, and the mean ± SEM are shown. Data 
are pooled from two independent experiments with a 
total of nine mice per group. (B) At day 11 after infec-
tion, CD4+ T cells were purified and the expression of 
Il17a, Rorc, and Irf4 were determined by real-time PCR. 
The means ± SD are shown (n = 5 mice per group from 
two independent experiments). (C) IL-17A expression by 
LP CD4+ T cells was determined by intracellular staining  
4 h after stimulation with PMA and ionomycin (left). The 
mean percentage ± SD of IL-17A–producing CD4+ T cells 
is shown (right, n = 5 mice per group). Data are repre-
sentative of two independent experiments. (D) Histologi-
cal evaluation of representative H&E-stained slides of 
the colon from WT and DKI mice on day 11 of infection 
(n = 9 mice per group from 2 independent experiments). 
Accumulations of lymphocytes are indicated with black 
circles in WT or arrowheads in DKI mice (left, bar:  
100 µm). The thickness of the mucosa is indicated with a 
black line (middle, bar: 200 µm). Black arrows indicate 
goblet cells in the colon mucosa (right, bar: 200 µm).  
(E) The histopathological parameters were quantitated 
using a double-blinded visual scoring system as detailed 
in Materials and methods. Data are pooled from 2 inde-
pendent experiments with a total of 9 mice per group.   
*, P < 0.05 (unpaired two-tailed Student’s t test).
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plus nucleus between sorbitol-treated and -untreated cells), con-
sistent with the reduction seen in NFATc1 mRNA (Fig. 3 B). 
Notably, almost all of the NFATc1 that was expressed was 
excluded from the nuclear fraction. Therefore, activation of 
p38 via the MAPK cascade has acute and long-term effects 
on the ability TCR-mediated stimulation to induce and ac-
tivate NFATc1. This raised the possibility that NFATc1, 
a known p38 substrate (Porter et al., 2000), may be phos-
phorylated by classically but not alternatively activated p38. 
Although not mapped in mouse cells, in human cells the 
phosphorylation of NFATc1 S172 is known to cause cyto-
solic retention (Chow et al., 2000; Porter et al., 2000). There-
fore, we stimulated the human T leukemia cell line Jurkat via 
the TCR for 48 h, activated the MAPK cascade by treating 
with sorbitol for 30 min, and, after a 1-h rest, immunoblotted 
the cytosolic fraction with antibodies specific for phospho-
S172 NFATc1 (p-NFATc1; Fig. 3 G). Whereas stimulation 
via the TCR caused only a small increase in p-NFATc1, sor-
bitol treatment resulted in high levels. Similar to mouse CD4+ 
T cells, inhibition of either p38 or JNK reduced the phos-
phorylation to background levels, and inhibition of both re-
sulted in even lower levels. Consistent with its role in preventing 
nuclear translocation, p-NFATc1 was undetectable in the nu-
clear fractions of these cells (unpublished data). Importantly, 
whereas Zap70-activated p38 (p38 pY323) phosphorylated 
ATF2 (a substrate common to both classically and alterna-
tively activated p38), as well as MKK6-activated p38 (Fig. 3 H), 
there was a striking difference in their ability to phosphorylate 
NFATc1 (Fig. 3 I). NFATc1 S172 is known to be phosphory-
lated by JNK (Chow et al., 2000). To determine if classically 
activated p38 can directly target this residue, an in vitro kinase 
assay using recombinant material was performed. As shown in 
Fig. 3 J, NFATc1 S172 was phosphorylated by both kinases, 
consistent with the inhibitor data showing a contribution of 
both in the retention of NFATc1 in the cytosol. The appear-
ance of phosphorated S172 was accompanied by a shift in the 
migration of the recombinant NFATc1, another indication of 
its phosphorylation (Fig. 3 K). Therefore, NFATc1 phosphory-
lation and inactivation is performed by classically activated but 
not alternatively activated p38.
Stress-mediated activation of p38 interferes  
with TCR-mediated responses
To determine the functional consequences of MAPK cascade 
activation, CD4+ T cells were exposed to sorbitol, and then 
cultured under Th17-skewing conditions using anti-CD3/
CD28. Sorbitol treatment resulted in substantially reduced 
Irf4 and Rorc mRNA (Fig. 4 A), IL-17A protein (Fig. 4 B), 
Tbet (Fig. 4 C), and IFN- (Fig. 4 D). The reduced cytokine 
secretion was not due to diminished CD4+ T cell activation, per 
se, because sorbitol treatment had no effect on TCR-induced 
up-regulation of the activation markers CD69 and CD25 
(unpublished data). Furthermore, sorbitol treatment markedly 
reduced proliferation of CD4+ T cells to anti-CD3/CD28, 
likely because IRF4 is a positive regulator of T cell prolifera-
tion and effector function (Lohoff et al., 2002; Tominaga et al., 
the in vitro analyses, histological examination revealed much 
greater signs inflammation in the colons of WT compared 
with DKI mice, with greater lymphocyte infiltration in the 
LP (Fig. 2 D, left), increased mucosal thickness and hyper-
plastic and elongated crypts, sometimes with a pseudostrati-
fied appearance and obvious increased mitotic activity of 
enterocytes (Fig. 2 D, middle), as well as marked goblet cell 
depletion (Fig. 2 D, right). A semiquantitative histopatho-
logical analysis of multiple mice confirmed the diminished 
inflammation in the gut of DKI mice (Fig. 2 E).
MAPK-cascade activation of p38 inhibits functions 
mediated by alternatively activated p38
The existence of a TCR signaling-specific p38 activation 
pathway raises the possibility that activation of p38 via the 
otherwise universal mechanism, the MAPK cascade, is inef-
fective or even detrimental to functional responses, either of 
which is consistent with the finding that PMA plus ionomy-
cin is a poor inducer of p38-dependent NFATc1 and IRF4 
(Fig. 1 E). To ask if classical activation is detrimental, CD4+  
T cells were treated with stimuli that initiate the MAPK cascade 
by different mechanisms to activate p38: sorbitol (osmotic 
stress), low dose UVB (radiation), and PMA and ionomycin 
(Fig. 3 A). Whereas none of these stimuli up-regulated 
NFATc1 or IRF4 mRNA, they inhibited TCR-mediated 
alternative pathway up-regulation of NFATc1 and IRF4 
mRNA (Fig. 3 B) and IRF4 protein (Fig. 3 C). This was not 
because of toxicity, because these treatments caused little to 
no reduction in cell viability compared with medium alone 
(unpublished data). NFAT family members are inactivated by 
phosphorylation, which results in their retention in the cyto-
sol, and NFATc1 is a known substrate for p38 in vitro and 
in vivo (Porter et al., 2000). Indeed, in TCR-stimulated primary 
T cells NFATc1 was found predominantly in the nucleus, 
where it is active, and the cytosolic fraction migrated more 
slowly (5 kD) when resolved on 8% SDS-PAGE, reflecting 
its higher degree of phosphorylation (Fig. 3 D). The effect of 
MAPK cascade-activated p38 on NFATc1 activation was de-
termined by stimulating CD4+ T cells with anti-CD3/CD28 
for 48 h to allow up-regulation of NFATc1 expression, and 
then treatment with medium or sorbitol for 30 min followed 
by resting the cells for another 1 h. TCR-mediated activation 
induced accumulation of NFATc1 in the cytosol and the 
transcriptionally active nuclear fraction (Fig. 3 E). Strikingly, 
osmotic stress caused egress of NFATc1 from the nucleus to 
the cytosol, which was largely prevented by addition of the 
p38 inhibitor SB203580 just before sorbitol treatment. 
Notably, inhibition of the other major stress kinase, JNK, by 
SP600125 also prevented the translocation of NFATc1 from 
the nucleus to the cytosol, and inhibiting both p38 and 
JNK was additive, resulting the greatest nuclear-to-cytosolic 
NFATc1 ratio. The effect of MAPK cascade activation on 
NFATc1 localization was even apparent when the brief sor-
bitol treatment was performed at the beginning of the 48-h 
period of activation (Fig. 3 F). In this case, sorbitol caused a 
reduction in total NFATc1 (compare NFATc1 in the cytosol 
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Figure 3. MAPK-cascade activated p38 inhibits functions distal to alternatively activated p38. (A) Purified CD4+ T cells were cultured overnight 
without stimulation, and then treated with either UV (50 J/m2 or 100 J/m2 or 200 J/m2), 0.6 M sorbitol for 30 min, or PMA (10 ng/ml) and ionomycin  
(1 µg/ml) for 1 h. Cell lysates were immunoblotted with anti-phospho-p38. The results are representative of three independent experiments. (B) Purified 
CD4+ T cells were treated with either 0.6 M sorbitol for 30 min, 50 J/m2 UV, or PMA and ionomycin were stimulated with anti-CD3/CD28 for 24 h. The 
expression of Nfatc1 and Irf4 was determined by quantitative real-time PCR. Results are the mean ± SEM of three independent experiments. *, P < 0.05 
(unpaired two-tailed Student’s t test). (C) Cells were treated as in B, and IRF4 expression was determined by Western blot. The results are representative of 
two independent experiments. (D) Freshly purified T cells were stimulated or not with anti-CD3/CD28 for 48 h. Cytosolic and nuclear fractions were sepa-
rated in a low percentage SDS-PAGE (8%) gel and immunoblotted for NFATc1. The results are representative of three independent experiments. (E) CD4+  
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however, far fewer of the activated T cells expressed IRF4 or 
IL-17A (Fig. 5 D, middle). Quantitation of biopsies from five 
pretreatment and three post-treatment psoriasis patients revealed 
that although UVB did not reduce the number of pY323+ in-
filtrating T cells, it caused a statistically significant reduction in 
the fraction that produced IRF4 and IL-17A (Fig. 5 E), consis-
tent with the ability of dual-phospho p38 to inhibit effector 
functions dependent on mono-phospho p38.
DISCUSSION
There is a great deal of evidence supporting a critical role for 
p38 in autoimmunity and inflammation (Lu et al., 2010; 
Jirmanova et al., 2011; Noubade et al., 2011), but little is 
known about the mechanism by which T cell p38, and in 
particular the alternative activation pathway downstream of 
TCR occupancy, contributes. Using pharmacologic and ge-
netic approaches, we have found that the Zap70-mediated 
p38 alternative activation pathway is required for up-regulation 
of NFATc1 and IRF4, critical transcription factors for proin-
flammatory cytokine production, in TCR-activated primary 
T cells in vitro and in vivo. This is in agreement with previous 
indirect evidence showing that Dlgh1, a p38-binding scaf-
fold protein involved in activation of the alternative pathway, 
plays a positive role in TCR-mediated induction of NFATc1 
(Round et al., 2007). Notably, activation of the p38 via the 
MAPK cascade was incapable of causing NFATc1 and IRF4 
up-regulation, and actually antagonized the action of alterna-
tively activated p38. These observations provide a satisfying 
explanation for why T cells have acquired a unique p38 acti-
vation pathway: to allow induction of biologically important 
transcriptional events that would otherwise be prevented by 
MAPK cascade-activated p38. They also resolve the paradox 
that phosphorylation of NFATc1 by p38 has been shown to 
cause its inactivation by retention in the cytosol, yet p38 is es-
sential for the production of many NFATc1-dependent cyto-
kines in TCR-activated T cells (Wu et al., 2003). The answer 
lies in the finding that unlike MKK-phosphorylated p38, 
NFATc1 is a poor substrate for Zap70-phoshorylated p38. 
Therefore, TCR signaling does not inhibit NFATc1-dependent 
transcriptional activity. We found that inhibition of JNK, 
2003; Brüstle et al., 2007; Fig. 4 E, left). This was not due to a 
toxic effect of osmotic stress, because the same T cells prolifer-
ated normally when stimulated with PMA and ionomycin, 
which bypasses the TCR, and thus the alternative p38 path-
way (Fig. 4 E, right).
Effect of UV on skin-infiltrating T cell activation
To ask if activation of p38 via a stress pathway could affect 
T cell responses in a biologically relevant setting, we character-
ized p38 activation and Irf4-induction in T cells from UV-
treated skin. Once after exposure to the minimum erythema 
dose (MED) of UV there was a marked increase in dual-phospho 
p38 in keratinocytes, dermal fibroblasts, and skin-resident 
T cells (Fig. 5 A). Strikingly, TCR-mediated stimulation of 
CD4+ T cells isolated from UV-treated skin induced Irf4 at 
much lower levels than in T cells from untreated skin, whereas 
there was relatively little effect on Irf8 (Fig. 5 B).
Psoriasis is a Th17-dependent inflammatory disease of the 
skin that is responsive to treatment with UV (phototherapy; 
Grundmann-Kollmann et al., 2002; Rácz et al., 2011). Given 
the finding that UV inhibited TCR-induced Irf4-induction 
in skin-resident T cells, we asked if the p38 alternative path-
way is active in skin-infiltrating T cells in human psoriatic 
lesions. Skin sections of patients with active psoriasis were 
stained with antibodies specific for p38 pY323. Whereas no 
staining was detected in T cell–poor areas, in T cell–rich re-
gions the majority of cells expressed Y323-phosphorylated 
p38 (Fig. 5 C). Given that pY323 is generated only in re-
sponse to TCR-mediated signals, this argues strongly that the 
skin-infiltrating cells are actively responding to local antigens. 
To determine if UV therapy interfered with the consequences 
of alternative p38-dependent T cell signaling, we examined 
biopsies taken from patients pre- or post-treatment with UVB. 
Fluorescent staining found that >20% of the p38-pY323 cells 
also expressed IRF4 and IL-17A (triple positive), indicating 
that the major source of IL-17A in the affected skin was from 
TCR-activated T cells (Fig. 5 D, top). After a cycle of treat-
ment with UVB, the number of p38-pY323+ cells was un-
changed, demonstrating that UV had little or no effect on 
T cell infiltration or TCR-mediated p38 activation. Strikingly, 
T cells were stimulated for 48 h with anti-CD3/CD28, and then treated with sorbitol in the presence or absence of SB203580 and/or SP600125 for 30 min, 
rested for 1 h, then immunoblotted for NFATc1 in cytosolic and nuclear fractions. Results are representative of three independent experiments. (F) Puri-
fied CD4+ T cells were treated or not with sorbitol for 30 min and stimulated with anti-CD3/CD28 for 48 h, and then immunoblotted for NFATc1 in cyto-
solic and nuclear fractions. The results are representative of three independent experiments. (G) Jurkat T cells were stimulated for 48 h with an agonistic 
anti-TCR antibody (C305), and then treated with sorbitol in the presence or absence of SB203580 and/or SP600125 for 30 min. After 1 h without further 
stimulation, cytosolic fractions were immunoblotted for phospho-NFATc1 (p-NFATc1). The results are representative of three independent experiments. 
(H) Recombinant p38 was activated with Zap70, MKK6, or buffer alone in in vitro kinase buffer. After 1 h, recombinant ATF2 and 10 µCi [32P]ATP were 
added for 30 min before separation on SDS-PAGE and PhosphorImager analysis. The phosphorylation state of p38 Y323 was determined by immuno-
blotting. The results are representative of three independent experiments. (I) Recombinant p38 was activated with Zap70, MKK6, or buffer alone and an  
in vitro kinase assay using recombinant NFATc1 as substrate was performed as in (H). The results are representative of two independent experiments.  
(J) Recombinant p38 was activated with MKK6 or buffer alone in in vitro kinase buffer. Active JNK1 was kept in in vitro kinase buffer. After 1 h, recombi-
nant NFATc1 was added and incubated for an additional hour before separation on SDS-PAGE and immunoblotting with an antibody specific for NFATc1 
phosphorylated on residue S172. The results are representative of two independent experiments. (K) Recombinant p38 was activated with Zap70, MKK6, 
or buffer alone in an in vitro kinase assay with recombinant NFATc1 as the p38 substrate, as in I. Samples were separated on a low percentage SDS-PAGE 
(8%) and immunoblotted for NFATc1 phosphorylated on residue S172. The results are representative of three independent experiments.
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but not MAPK cascade-activated p38 that result in up-regulation 
of Nfatc1 transcription remain to be determined.
The results in this study show that TCR-induced NFATc1/ 
IRF4-dependent IL-17 production is mediated by the alter-
native p38 activation pathway. There are other, perhaps non-
physiologic, means one can use to achieve IL-17 production 
as well. This is indicated by the ability of PMA and ionomy-
cin, which bypass proximal TCR signaling, to activate the clas-
sical p38 cascade and, although doing so less well, inducing 
another stress kinase that can phosphorylate NFTAc1 S172 
(Chow et al., 2000), also had a partial effect on NFATc1 nu-
clear translocation. Although we can’t exclude the possibility 
that stress-activated signaling events other than p38 and JNK 
activation might influence NFATc1 translocation, our finding 
that inhibition of both p38 and JNK almost completely pre-
vented NFATc1 retention in the cytosol suggests that these 
two kinases are the major contributors to stress-induced NFATc1 
inhibition. The molecular events downstream of alternatively 
Figure 4. MAPK cascade–activated p38 inhibits T cell proliferation and effector function mediated by alternatively activated p38.  
(A and B) Naive CD4+ T cells were treated with 0.6 M sorbitol for 30 min or untreated, and then stimulated with anti-CD3/CD28 in neutral or Th17-skewing 
conditions. After 2 d, Irf4 and Rorc mRNA levels were analyzed by quantitative real-time PCR (A), and after 3 d, IL-17A expression was determined in cells 
restimulated with PMA and ionomycin for 4 h. (B) The numbers indicate the frequency of IL-17A–producing cells. The results are representative of two 
independent experiments. (C and D) Naive CD4+ T cells were treated as in A, and then stimulated with anti-CD3/CD28 either in neutral (Th0) or Th1 skew-
ing conditions for 2 d, at which time Tbet mRNA was measured by real-time PCR (C), and after 3 d cells were restimulated with PMA and ionomycin for  
4 h and intracellular IFN- expression was measured by flow cytometry (D). The numbers indicate the frequency of IFN-–producing cells. *, P < 0.05 
(unpaired two-tailed Student’s t test). Data are representative of at least three independent experiments. (E) T cells were stimulated with the indicated 
concentrations of anti-CD3 in the presence of anti-CD28 (wells coated with 2 µg/ml) or PMA and ionomycin for 48 h and proliferation was assessed by 
[3H]thymidine incorporation. Data shown are representative of at least three independent experiments.
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family members, in particular NFATc2 (Ghosh et al., 2010). 
Another study described a positive role for MAPK cascade-
activated p38 in T cell IL-17 production (Noubade et al., 2011). 
Although most of the experiments used chemical inhibitors 
T cell IL-17 production despite much less NFATc1 and IRF4 
up-regulation (Fig. 1, E and F). It is possible that this is because 
the very strong Ca2+ signal triggered by the calcium iono-
phore ionomycin activates other, constitutively expressed NFAT 
Figure 5. Effect of UV on skin-infiltrating  
T cells. (A) Mice were exposed or not to UV radia-
tion as described in Materials and methods and, 1 h 
later, skin sections were obtained and immuno-
stained for CD3 (not depicted) and dual phospho-
p38 (pT180/pY182). Phospho-p38–positive T cells 
are indicated with arrowheads, keratinocytes with 
arrows, and dermal fibroblasts with asterisks. Bars: 
200 µm (left); 100 µm(right). Data are representa-
tive of five mice per group from two independent 
experiments. (B) Purified CD4+ T cells from the skin 
of UV treated or untreated mice were stimulated  
in vitro with anti-CD3/CD28 for 24 h, and Irf4 mRNA 
expression was measured by real-time PCR. Results 
are the mean ± SEM of two independent experi-
ments with a total of 5 mice per group. *, P < 0.05, 
NS, not statistically significant (unpaired two-tailed 
Student’s t test). (C) Immunohistochemical staining 
of human psoriatic skin lesions with anti-CD3 or 
phospho-p38 Y323 (p38 pY323)-specific antibod-
ies. The insets in the middle pane show the T cell–
poor and T cell–rich areas that are enlarged in the 
left and right panes for CD3 and the top and bot-
tom panes for p38 pY323. Arrows indicate exam-
ples of p38 pY323-positive cells (n = 3 patients; 
Bars: 1 mm (middle); 50 µm (outer panels).  
(D) Immunofluorescence staining for p38 pY323 
(cyan), IRF4 (green), IL-17A (red), and the corre-
sponding isotype control of representative psoriatic 
skin lesions biopsies before and after UVB treat-
ment (Bar, 100 µm). (E) Quantitation of p38 pY323+ 
cells that are also positive for IRF4 and IL-17A  
(triple positive) in the skin of 6 patients before  
treatment and 3 of these after UVB treatment.  
*, P < 0.05. NS, not significant (unpaired two-tailed 
Student’s t test).
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therapeutic effects of phototherapy in clinical settings. UV has 
been used to treat psoriasis, a chronic T cell–mediated skin 
disease in which Th17 cells play a key pathological role (Fitch 
et al., 2007), and that therapy with anti–IL-17 or anti–IL-17R 
is remarkably effective (Leonardi et al., 2012; Papp et al., 
2012). Initially, attention largely focused on the direct effects 
of UV on keratinocytes, such as induction of apoptosis and 
reduction of proliferation, which have been shown to be 
mechanisms for psoriatic plaque clearance after UVB treat-
ment (Erkin et al., 2007; Weatherhead et al., 2011). Notably, 
the percentage of IFN-– but not IL-2–producing T cells has 
been shown to be decreased in the course of UVB treatment 
(Walters et al., 2003), which parallels the finding that produc-
tion of IFN- but not IL-2 was reduced in TCR-stimulated 
DKI T cells (Jirmanova et al., 2009). In addition, skin from 
UV-treated patients has been reported to have reduced tran-
scripts of genes involved in Th17 and type I and II interferon 
signaling (Rácz et al., 2011). Interestingly, UVB irradiation 
induces RANKL expression in keratinocytes and systemic 
immunosuppression (Loser et al., 2006). Given that RANKL 
has been shown to activate stress kinases like p38 by the 
MAPK cascade (Matsumoto et al., 2000), it is possible that 
RANKL produced by keratinocytes contributes to inhibi-
tion by activating the classical p38 pathway in pathogenic 
T cells, thereby dampening the immune response. This would 
be another, indirect, means by which the MAPK cascade 
could antagonize biological events downstream of alterna-
tively activated p38.
In the present study, we found that the majority of cells in 
psoriatic lesions that were positive for IL-17A (and IRF4) 
were T cells in which the p38 alternative activation pathway 
was active. UVB treatment did not reduce the number of p38 
pY323-positive cells, but did reduce their ability to produce 
IL-17A. The results suggest that the beneficial effects of UV 
radiation are, at least in part, due to activation of the classical 
MAPK cascade with a resulting reduction in NFATc1 activ-
ity and proinflammatory cytokine production by pathogenic 
T cells.
MATERIALS AND METHODS
Mice. Mice expressing p38Y323F, in which endogenous p38 and p38 
contain a Tyr→Phe substitution at residue 323 (double knock-in, or DKI 
mice; Jirmanova et al., 2011), were crossed onto C57BL/6 (B6) for at least 12 
generations. Mice were maintained in the National Cancer Institute patho-
gen-free animal facility, and all animal experiments were performed under a 
National Institutes of Health–approved animal study protocol.
Cells. Primary CD4+ T cells were purified from spleens of 6–12-wk-old B6 
or DKI mice using negative-selection T cell purification columns (CL101; 
Cedarlane). Purified CD4+ T cells were cultured in RPMI 1640 medium 
supplemented with 10% fetal bovine serum (Invitrogen), 2 mM glutamine, 
50 µM -mercaptoethanol, and 100 µM gentamicin (complete medium).
Reagents. Mouse-specific antibodies against p38 (5F11; Cell Signaling 
Technology), CD4 (RM4-5; BD Biosciences), CD8 (53–6.7; BD), IL-17 
(eBio17B7; eBioscience), and IFN- (XMG1.2; eBioscience) were used. 
Anti-CD3 (145-2C11) and anti-CD28 (37.51) were purchased from BD. 
or dominant negative p38, which would affect p38 activated 
by both pathways, in some experiments MKK3-deficient and 
MKK6 haplozygous T cells were found to have decreased IL-17 
in response to anti-CD3. Interestingly, and in distinction to the 
findings in the present report, it was found that MAPK cas-
cade-activated p38 was not required in Th17-skewed cells for 
Rorc or Il17 mRNA production, but rather for activation of 
the translation initiation factor eIF-4E–MNK pathway and 
promotion of IL-17 protein translation. Our data, on the other 
hand, demonstrate that the alternative p38 pathway is required 
for transcriptional up-regulation of Nfatc1, Irf4, Rorc, and Il17a. 
These are not mutually exclusive observations, and it is possi-
ble that the regulated balance of the two (transcription and 
translation) might have a biphasic effect on biological responses 
downstream of p38.
Although this study focused on IL-17, a diminished 
NFATc1 and IRF4 response in mice lacking the alternative 
p38 activation pathway would be expected to have an impact 
on several proinflammatory cytokines. Blastocyst comple-
mentation assays with NFATc1 knockout embryonic stem 
cells found that IL-4 but not TNF and IFN- production 
was diminished (Yoshida et al., 1998). Fetal liver chimeras in 
which both NFATc1 and NFATc2 were knocked out had 
more extensive cytokine deficiencies, with reductions in IL-2, 
IL-4, IFN-, and IL-5 (Peng et al., 2001). In this regard, we 
previously found that IFN- but not IL-4 expression was di-
minished in T cells from DKI mice, which is consistent with 
their rapid loss of T-bet expression after activation (Jirmanova 
et al., 2009). It is possible that p38 alternative activation path-
way controls NFATc1 expression indirectly by promoting 
nuclear translocation of NFATc2 via phosphorylation of con-
served residues critical for transactivation. Consistent with 
this, DKI T cells had impaired production of TNF (unpub-
lished data), which is downstream of NFATc2 (Kaminuma 
et al., 2008), and MAPK-activated p38 is known to phosphory-
lated and inactivated NFATc2 (Gómez del Arco et al., 2000). 
Whether NFATc2 is also a substrate for alternatively activated 
p38, and if so at what sites, remains to be determined.
The Gram-negative bacterium C. rodentium (a rodent 
equivalent of enteropathogenic Escherichia coli) causes a robust 
colonic Th17 response by the second week after infection 
(Bry and Brenner, 2004; Symonds et al., 2009). Although + 
T cells can secrete IL-17 (Poggi et al., 2009; Silva-Santos, 
2011), it is IL-17–producing + CD4+ T cells that play a 
protective role, because mice lacking CD4+  T cells exhib-
ited substantial mortality when infected with C. rodentium, 
whereas mice lacking + or CD8+  cells survived (Bry 
and Brenner, 2004). The finding that DKI CD4+  T cells in 
the lamina propria had diminished levels of Rorc and Irf4, and 
that the mice failed to mount a normal Th17 response, indicates 
that protective adaptive immunity to C. rodentium is strictly 
dependent on p38 activation, in particular p38 activated via 
TCR engagement.
The findings that cytokine responses mediated by the al-
ternative p38 pathway are diminished by activating the classi-
cal p38 pathway may have implications for understanding the 
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data were normalized to HPRT (hypoxanthine-guanine phosphoribosyl 
transferase) and were presented as relative expression to the background value. 
The primers used in this study for real-time PCR are as follows: Irf4-Fwd, 5-
GCAGCTCACTTTGGATGACA-3, Rev, 5-CCAAACGTCACAGGACA-
TTG-3; Irf1-Fwd, 5-GCAAAACCAAGAGGAAGCTG-3, Rev, 5-CAG-
AGAGACTGCTGCTGACG-3; Irf8-Fwd, 5-GATCGAACAGATCGA-
CAGCA-3, Rev, 5-GCTGGTTCAGCTTTGTCTCC-3; Nfatc1-Fwd, 
5-CGTACCTTCCTGCCAATGTT-3, Rev, 5-TGGTGAGCTGTTG-
GCTGTAG-3; Nfatc2-Fwd, 5-TCTGCTGTTCTCATGGATGC-3, 
Rev, 5-TCCTCTCCTCCTGCTCACAT-3; Nfatc3-Fwd, 5-TCCAC-
TTGAGCCATCCTACC-3, Rev, 5-AGAGCCACCTGGAGAAG-
TCA-3; Nfat5-Fwd, 5-GCGGACAGTATCCGGTTAAA-3, Rev, 
5-TGCAACACCACTGGTTCATT-3; Hprt-Fwd, 5-AGCCTAAGAT-
GAGCGCAAGT-3, Rev, 5-TTACTAGGCAGATGGCCACA-3; Rorc-Fwd, 
5-TGCAAGACTCATCGACAAGG-3, Rev, 5-AGGGGATTCAACAT-
CAGTGC-3; Tbet-Fwd, 5-TCAACCAGCACCAGACAGAG-3, Rev, 
5-AAACATCCTGTAATGGCTTGTG-3; Il17a-Fwd, 5-GCTCCA-
GAAGGCCCTCAGA-3, Rev, 5-CTTTCCCTCCGCATTGACA-3.
In vitro kinase assay. Purified recombinant mouse His-p38 was activated 
or not by incubation with either 300 ng of active Zap70 (R&D Systems) or 
1 µg of active MKK6 at 30°C in 20 µl of kinase buffer (20 mM Tris, pH 7.5, 
20 mM MgCl2, 1 mM dithiothreitol [DTT], 10 mM -glycerophosphate, and 
1 mM Na3VO4 and 50 µM ATP). After 1 h, 1 µg ATF2 or NFATc1 and 10 µCi 
[32P]ATP were added and incubation proceeded for 45 min at 30°C. Phos-
phorylated products were resolved by SDS-PAGE, transferred to nitrocellulose 
membranes, and visualized with a Storm PhosphorImager (GE Healthcare).
Activation of the MAPK cascade p38 activation pathway. Purified 
CD4+ T cells were treated with sorbitol (0.6 M) for 30 min at 37°C in com-
plete medium and washed once before plating. For activation with UV in vitro, 
cells were treated with 50 J/m2 UVB and washed once with complete me-
dium before plating. For mitogenic activation of the classical pathway, PMA 
was added in the cell culture at a concentration of 10 ng/ml in presence of 
ionomycin (1 µg/ml).
UV treatment and analysis of mouse skin-resident T cells. The back 
and flanks of 6–8-wk-old B6 mice were shaved before exposure to the mini-
mal erythema dose (MED) of UVA/UVB (9.6 KJ/m2 from a bank of FS40 
sunlamps, 60% UVB, 40% UVA, <1% UVC). 1 h later, the mice were eutha-
nized and the skins harvested for analysis. To purify CD4+ T cells, irradiated 
or unirradiated full-thickness skin without subcutaneous tissue was incubated 
for 1.75 h at 37°C in RPMI containing 400 µg/ml Liberase TL (Roche), at 
which time 0.1% DNase I (Sigma-Aldrich) was added (final concentration 
0.05%) for an additional 15 min. Single-cell suspensions were prepared by 
sequential filtering through 100-, 70-, and 40-µm nylon mesh, and then pas-
sage over Lympholyte M density gradients (Cedarlane) and centrifugation at 
1,000 g for 20 min at room temperature. Finally, CD4+ T cells were purified 
by positive selection using MACS columns.
C. rodentium infection. C. rodentium was prepared by selecting a single col-
ony and culturing in LB broth overnight. 6–12-wk-old pathogen-free female 
C57BL/6 mice were inoculated via oral gavage with 200 µl of the overnight 
culture. Colon biopsies were taken, formalin fixed, paraffin-embedded and 
H&E stained for histopathological analysis. Histological scoring was per-
formed by two double-blinded, experienced observers. The groups were en-
coded, and in all cases a consensus was obtained. In the case of divergent 
scoring, a third observer decided upon the final interpretation.
Immunohistochemistry. Paraffin-embedded tissue sections (4 µm) were 
analyzed using the avidin–biotin complex method (EnVision; Dako). Prior 
to incubation with primary antibody (rabbit polyclonal anti-CD3 [SP7; 
Abcam], rabbit polyclonal anti-T180/Y182 phospho-p38 [Cell Signaling 
Technology], or rabbit anti-pY323 p38 [ECM Biosciences]), antigen re-
trieval by heat pretreatment using citrate buffer (pH 6.1) was performed.
Phorbol myristate acetate (PMA) and ionomycin were purchased from Sigma-
Aldrich. Recombinant NFATc1 protein was purchased from SignalChem 
and anti-NFATc1 antibody (MA3-024) was purchased from Thermo Fisher 
Scientific. Anti–human phospho NFATc1 (S172; clone 679340) was pur-
chased from R&D Systems. Anti-IRF4 antibody was purchased from Cell 
Signaling Technology, and IRF8, from Invitrogen. Recombinant full-length 
NFATc1 was purchased from SignalChem. SB203580 (p38 inhibitor) and 
SP600125 (JNK inhibitor) were purchased from Cell Signaling Technology. 
[-32P]ATP was purchased from PerkinElmer.
Microarray analysis. Purified CD4+ T cells from WT and DKI mice were 
stimulated with anti-CD3/CD28 for 12 h, lysed, mRNA isolated, and re-
verse transcribed to cDNA, and microarray was performed using Affymetrix 
chips. The microarray data were analyzed by Partek software.
Intracellular cytokine staining. CD4+ T cells were stimulated with plate-
bound anti-CD3 (2 µg/ml) and anti-CD28 (2 µg/ml) in Th0 (neutral), Th1 
(10 ng/ml IL-12 and 10 µg/ml anti–IFN-), or Th17 (20 ng/ml IL-6, 5 ng/ml 
TGF, 10 µg/ml anti–IFN-, and 10 µg/ml anti–IL-4) conditions for 3 d. 
Skewed cells were placed in 96-well plates and restimulated with PMA 
(10 ng/ml) and ionomycin (1 µg/ml) in the presence of monensin (3 µM) for 
4 h at 37°C. Cells were then washed in FACS buffer (1% BSA plus 0.1% 
sodium azide) and fixed and permeabilized with Cytofix/Cytoperm solution 
for 25 min on ice, followed by washing in Perm/Wash solution (BD). Cells 
were stained for 30 min at room temperature with mAbs against IL-17A and 
IFN-, washed two times in Perm/Wash solution, and once with FACS buf-
fer, and analyzed by flow cytometry (FACSCalibur using CellQuest Pro 5.2.1 
software [BD]). Data were analyzed with FlowJo 9.2 software (Tree Star).
Histopathological analysis of gut sections. Two colon samples from 
each mouse (n = 9) were collected on day 11–12 after infection with C. ro-
dentium, fixed in buffered formalin, and embedded in paraffin. Paraffin blocks 
were cut into 4-µm sections and stained with hematoxylin and eosin (H&E). 
For the semiquantification of the inflammation, a previously described scor-
ing system (Galeazzi et al., 1999) was used with minor modifications. In brief, 
mucosal hyperplasia (increased mucosal thickness with crypt hyperplasia and 
elongation, formation of pseudoinvasive, pseudostratified, or pseudopolypous 
growth, increased mitotic activity) was scored as absent (0), mild (1), moder-
ate (2), or extensive (3). Goblet cell depletion was quantified similarly (scores 
of 0–3). The depth of inflammatory cell infiltration was scored as absent (0), 
mild (1) inflammation in mucosa and submucosa, moderate (2) inflammation 
to the lamina muscularis propria, or severe (3) transmural inflammation.
T cell proliferation assay. Purified CD4+ T cells were stimulated with 
plate-bound -CD3 (2 µg/ml) and -CD28 (2 µg/ml) for 48 h in 96-well 
flat-bottomed plates. Cells were pulsed with 1 µCi [3H]thymidine 14 h be-
fore harvesting. [3H]thymidine uptake was determined with a Wallac 1450 
MicroBeta Liquid Scintillation Counter.
Protein purification. Recombinant p38 and constitutively active MKK6 
(S207E/T211E) were purified as previously described (Mittelstadt et al., 
2009). In brief, p38 and MKK6 were expressed in the bacterial strain 
BL21(DE3) using the vector pET15b. After cultures reached an A600 of 0.5–
1.0, protein expression was induced with 0.5 mM isopropyl -D-thiogalac-
topyranoside (IPTG) and incubated overnight at 4°C. Cells were resuspended 
in ice-cold PBS, including 0.5 M NaCl, 0.1% Triton X-100, and 1 mM 
phenylmethylsulfonyl fluoride, sonicated, and centrifuged at 20,000 g for 
20 min at 4°C. Proteins were purified with cobalt-charged chelating–Sepharose 
Fast Flow beads (GE Healthcare) and eluted with 0.3 M imidazole in PBS 
with 0.5 M NaCl. Proteins were concentrated and washed into PBS using 
Microcon YM-30 spin columns (Millipore).
Real-time PCR. Total RNA was extracted with RNeasy mini-kit (QIAGEN). 
After reverse transcription using the Omniscript RT kit (QIAGEN), Power 
SYBR Green premix (Applied Biosystems) was used for quantitative PCR. All 
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